Media Coverage Mar 05 2018 Advancing Rare Disease Research Contract Pharma A record number of personalized medicines were approved by the FDA in 2017. Managing Director, Antti Nurmi, Ph.D., explains how early research provides the crucial evidence needed to conduct clinical trials. Read the full article
Media Coverage Jim Foster Details ‘Enormous Opportunity’ in Drug Discovery on CNBC's Mad Money with Jim Cramer Learn More
Media Coverage Q: Although There Is no Such Thing As a Truly “Crisis-Proof” Organization, How Are You Working to Mitigate Risks for Future Crises Like the COVID-19 Pandemic? Learn More
Media Coverage Q: What Do You Think Is the Greatest Lesson Learned from the COVID-19 Pandemic, and What Lasting Impacts Do You Foresee Over the Next 5–10 Years? Learn More
